| [1] |
Reitz C, Pericak-Vance MA, Foroud T, et al. A global view of the genetic basis of Alzheimer disease[J]. Nat Rev Neurol, 2023,19:261-277. doi:10.1038/s41582-023-00789-z.
|
| [2] |
Colonna M, Butovsky O. Microglia function in the central nervous system during health and neurodegeneration[J]. Annu Rev Immunol, 2017,35:441-468. doi:10.1146/annurev-immunol-051116-052358.
|
| [3] |
Cary GA, Wiley JC, Gockley J, et al. Genetic and multi-omic risk assessment of alzheimer′s disease implicates core associated biological domains[J]. Alzheimers Dement(N Y),2024,10: e12461.doi:10.1002/trc2.12461.
|
| [4] |
Szántó M, Gupte R, Kraus WL, et al. Parps in lipid metabolism and related diseases[J]. Prog Lipid Res, 2021,84:101117. doi:10.1016/j.plipres.2021.101117.
|
| [5] |
Vida A, Márton J, Mikó E, et al. Metabolic roles of poly(adp-ribose) polymerases[J]. Semin Cell Dev Biol, 2017,63:135-143. doi:10.1016/j.semcdb.2016.12.009.
|
| [6] |
Zhu H, Zheng C. When PARPs meet antiviral innate immunity[J]. Trends Microbiol, 2021,29:776-778. doi:10.1016/j.tim.2021.01.002.
|
| [7] |
Zhang Y, Chen JC, Zheng JH, et al. Pterosin b improves cognitive dysfunction by promoting microglia M1/M2 polarization through inhibiting KLF5/PARP14 pathway[J]. Phytomedicine, 2024,135:156152. doi:10.1016/j.phymed.2024.156152.
|
| [8] |
Brooks DM, Anand S, Cohen MS. Immunomodulatory roles of parps: shaping the tumor microenvironment, one adp-ribose at a time[J]. Curr Opin Chem Biol,2023,77:102402. doi:10.1016/j.cbpa.2023.102402.
|
| [9] |
Imai S, Guarente L. Nad+ and sirtuins in aging and disease[J]. Trends Cell Biol, 2014,24:464-471. doi:10.1016/j.tcb.2014.04.002.
|